Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Gland Pharma Ltd.	HALFYEARLY RESULTS

NSE: GLANDEQ BSE: 543245ISIN: INE068V01023INDUSTRY: Pharmaceuticals

BSE

Rs 1867.10

Open: 1915.00

Today's Range 1855.30

1930.00

NSE
Rs 1868.30
-29.90 ( -1.60 %)

-28.05 ( -1.50 %)

Prev Close: 1895.15

52 Week Range 1453.00

2130.00

You can view the Halfyearly Results for the last 5 years.

Market Cap. (Rs.)	30781.44 Cr.	P/BV	3.13	Book Value (Rs.)	596.28
52 Week High/Low (Rs.)	2131/1452	FV/ML	1/1	P/E(X)	29.96
Bookclosure	11/08/2026	EPS (Rs.)	62.35	Div Yield (%)	0.00

(Rs. in Crs.)

Particulars	Mar 26	Sep 25	Mar 25	Sep 24	Mar 24
Net Sales/Income from operations	3438.15	2992.50	2808.96	2807.54	3082.61
Total Income From Operations	3438.15	2992.50	2808.96	2807.54	3082.61

EXPENDITURE
Consumption of Raw Materials	1123.96	1115.79	1024.95	947.53	1038.69
Purchase of Traded Goods	3.78	2.83	5.25	9.24	13.14
Increase/Decrease in Stocks	40.24	-43.67	-79.54	182.95	146.80
Power & Fuel	107.03	95.82	107.26	91.89	121.92
Employees Cost	835.77	793.07	716.22	685.34	696.94
Depreciation	216.31	207.36	192.09	185.79	197.95
Other Expenses	379.47	347.01	327.35	329.14	350.09
Total Expenses	2706.56	2518.21	2293.58	2431.88	2565.52

P/L Before Other Inc. , Int., Excpt. Items & Tax	731.59	474.29	515.38	375.67	517.09
Other Income	174.64	141.69	102.52	111.09	79.54
P/L Before Interest, Excpt. Items & Tax	906.23	615.98	617.91	486.75	596.63
Interest	13.96	19.32	30.27	11.73	15.24
P/L Before Exceptional Items & Tax	892.27	596.66	587.64	475.02	581.39
Exceptional Items	-24.35	0.00	0.00	0.00	0.00
P/L Before Tax	867.92	596.66	587.64	475.02	581.39
Tax	239.77	197.49	196.40	167.73	197.11
P/L After Tax from Ordinary Activities	628.15	399.17	391.23	307.29	384.28
Net Profit/Loss For the Period	628.15	399.17	391.23	307.29	384.28
Net P/L After Minority Interest & Share Of Associates	628.15	399.17	391.23	307.29	384.28

Equity Share Capital	16.48	16.48	16.48	16.48	16.47
EPS Before Extra Ordinary *
Basic EPS (Rs.)	38.13	24.23	23.75	18.65	23.33
Diluted EPS (Rs.)	38.12	24.23	23.74	18.65	23.33
EPS After Extra Ordinary *
Basic EPS (Rs.)	38.13	24.23	23.75	18.65	23.33
Diluted EPS (Rs.)	38.12	24.23	23.74	18.65	23.33

PBITOE Margin (%)	21.27	15.84	18.34	13.38	16.77
PBTE Margin (%)	25.95	19.93	20.92	16.91	18.86
PBT Margin (%)	25.24	19.93	20.92	16.91	18.86
PAT Margin (%)	18.26	13.33	13.92	10.94	12.46
PAT After MI And SOA Margin (%)	18.26	13.33	13.92	10.94	12.46

Market

Derivatives

Mutual Fund

IPO

Quick Links

Gland Pharma Ltd.

HALFYEARLY RESULTS